Rates of significant disease reactivation were similar more than 1 year after randomization for patients assigned to mycophenolate mofetil (MMF) withdrawal or MMF maintenance.
Cabaletta Bio: Two Differentiated CAR-T Platforms To Carry It Forward (NASDAQ:CABA) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Closing of Transaction with Pierre Fabre Laboratories to Expand Global Tab-cel® Partnership
Tab-cel BLA on Track for Submission in Q2 2024 Following Positive New Data from Pivotal ALLELE.
Sodium-glucose cotransporter-2 inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs of benefits in these conditions.
Sana Biotechnology: SC291 Moving Forward Beyond Hematological Malignancies (NASDAQ:SANA) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.